Zusammenfassung
Untersuchungen immunologischer Aspekte der embryo-maternalen Interaktionen nehmen in der Reproduktionsmedizin eine immer größere Rolle ein. Störungen von Adhäsion, Invasion und Implantation der semi-allogenen Blastozyste in das rezeptive Endometrium werden als Ursache für Fehlgeburten oder andere – spätere – Schwangerschaftskomplikationen angesehen. Bis dato sind diese hochspezifischen, synchronen Abläufe an der embryo-maternalen Grenzfläche nur unzureichend verstanden. Die Gabe von aus anderen Indikationen als wirksam bekannten Medikamenten muss sich immer vor dem Hintergrund einer korrekten „immunologischen Diagnose“, zutreffender Indikation und dem potenziellen Nebenwirkungsspektrum der Präparate messen lassen. Da aufgrund der Studienlage evidenzbasierte Vorgehensweisen in aller Regel nicht gegeben sind, ist vom routinemäßigen Einsatz immunmodulatorischer Präparate außerhalb von Studien bis dato abzuraten.
Literatur
Agrawal S, Pandey MK, Mandal S, Mishra L, Agarwal S (2002) Humoral immune response to an allogenic foetus in normal fertile women and recurrent aborters. BMC Pregnancy Childbirth 2:6
Alecsandru D, García-Velasco JA (2017) Why natural killer cells are not enough: a further understanding of killer immunoglobulin-like receptor and human leukocyte antigen. Fertil Steril 107:1273–1278
Bohlmann MK (2011) Effects and effectiveness of heparin in assisted reproduction. J Reprod Immunol 90:82–90
Bohlmann MK, Lüdders DW, Baumann K, Speer R, Marx TE, Diedrich K, Hornemann A (2008) Gestagenanwendung in der Schwangerschaft. Gynäkol Endokrinol 6:171–176
Bohlmann MK, Luedders DW, Weichert J, Baumann K, Thill M, Diedrich K, Schleussner E, Hornemann A (2009) Thrombophile Gerinnungsstörungen als Risikofaktoren für habituelle Aborte. Gynäkologe 42:17–24
Bohlmann MK, Toth B, Schleussner E (2010) Keine generelle Heparinisierung bei habituellen Aborten. Frauenarzt 51:1020–1021
Carp HJ, Toder V, Mashiach S, Rabinovici J (1994) Effect of paternal leukocyte immunization on implantation after biochemical pregnancies and repeated failure of embryo transfer. Am J Reprod Immunol 31:112–115
Carrington B, Sacks G, Regan L (2005) Recurrent miscarriage: pathophysiology and outcome. Curr Opin Obstet Gynecol 17:591–597
Carter JD, Valeriano J, Vasey FB (2006) Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship. J Rheumatol 33:1014–1017
Clark DA (2010) Anti-TNF alpha therapy in immune-mediated subfertility: state of the art. J Reprod Immunol 85:15–24
Clowse ME (2010) The use of anti-TNFα medications for rheumatologic disease in pregnancy. Int J Womens Health 2:199–209
Davari-Tanha F, Shahrokh Tehraninejad E, Ghazi M, Shahraki Z (2016) The role of G-CSF in recurrent implantation failure: a randomized double blind placebo control trial. Int J Reprod Biomed (Yazd) 14:737–742
Daya S, Gunby J (2004) Luteal phase support in assisted reproduction cycles. Cochrane Database Syst Rev (3):CD004830
Fahey JV, Schaefer TM, Channon JY, Wira CR (2005) Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract. Hum Reprod 20:1439–1446
Franasiak JM, Scott RT (2017) Contribution of immunology to implantation failure of euploid embryos. Fertil Steril 107:1279–1283
Gleicher N, Vidali A, Barad DH (2011) Successful treatment of unresponsive thin endometrium. Fertil Steril 95(2123):e13–e17
Gutschalk CM, Herold-Mende CC, Fusenig NE, Mueller MM (2006) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Cancer Res 66:8026–8036
Haas DM, Ramsey PS (2013) Progestogen for preventing miscarriage. Cochrane Database Syst Rev (10):CD003511
Haider S, Knöfler M (2009) Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta 30:111–123
Hofer S, Heindl B, Meister FC, Maul H, Martin E, Sohn C, Weigand MA (2009) Blutungen während Schwangerschaft und Geburt. Gynäkologe 42:55–69
Ito K, Tanaka T, Tsutsumi N, Obata F, Kashiwagi N (1999) Possible mechanisms of immunotherapy for maintaining pregnancy in recurrent spontaneous aborters: analysis of anti-idiotypic antibodies directed against autologous T-cell receptors. Hum Reprod 14:650–655
Kallen CB, Arici A (2003) Immune testing in fertility practice: truth or deception? Curr Opin Obstet Gynecol 18:440–445
Kämmerer U, von Wolff M, Markert UR (2004) Immunology of human endometrium. Immunobiology 209:569–574
Kleinstein J (2009) Aktive und passive Immunisierung. Gyn Endokrinol 7:87–92
Kling C, Steinmann J, Westphal E, Magez J, Kabelitz D (2006) Adverse effects of intradermal allogeneic lymphocyte immunotherapy: acute reactions and role of autoimmunity. Hum Reprod 21:429–435
Kling C, Schmutzler A, Wilke G, Hedderich J, Kabelitz D (2008) Two-year outcome after recurrent implantation failure: prognostic factors and additional interventions. Arch Gynecol Obstet 278:135–142
Lédée N, Petitbarat M, Rahmati M, Dubanchet S, Chaouat G, Sandra O, Perrier-d’Hauterive S, Munaut C, Foidart JM (2011) New pre-conception immune biomarkers for clinical practice: interleukin-18, interleukin-15 and TWEAK on the endometrial side, G-CSF on the follicular side. J Reprod Immunol 88:118–123
Li J, Chen Y, Liu C, Hu Y, Li L (2013) Intravenous immunoglobulin treatment for repeated IVF/ICSI failure and unexplained infertility: a systematic review and a meta-analysis. Am J Reprod Immunol 70:434–447
Matsuyama T, Kobayashi Y, Honda I, Inoue M, Fujii A (1992) Analysis of HLA antigens and immunotherapy for infertile couples who failed to conceive after in vitro fertilization-embryo tubal replacement (IVF-ETR). Nihon Sanka Fujinka Gakkai Zasshi 44:1241–1247
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306
Moffett A, Shreeve N (2015) First do no harm: uterine natural killer (NK) cells in assisted reproduction. Hum Reprod 30:1519–1525
Nelson SM, Greer IA (2008) The potential role of heparin in assisted conception. Hum Reprod Update 14:623–645
Oates-Whitehead RM, Haas DM, Carrier JA (2003) Progestogen for preventing miscarriage. Cochrane Database Syst Rev (4):CD003511
Pandey MK, Rani R, Agrawal S (2005) An update in recurrent spontaneous abortion. Arch Gynecol Obstet 272:95–108
Parham P (2004) NK cells and trophoblasts: partners in pregnancy. J Exp Med 200:951–955
Paulmyer-Lacroix O, Despierres L, Courbiere B, Bardin N (2014) Antiphospholipid antibodies in women undergoing in vitro fertilization treatment: clinical value of IgA anti-β2glycoprotein I antibodies determination. Biomed Res Int 2014, Art.314704
Piccinni MP, Giudizi MG, Biagiotti R, Beloni L, Giannarini L, Zampognaro S, Parrochi P, Manetti R, Annunziato F, Livi C, Romagnani S, Maggi E (1995) Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 155:128–133
Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S (1998) Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 4:1020–1024
Practice Committee of the American Society for Reproductive Medicine (2008) Definitions of infertility and recurrent pregnancy loss. Fertil Steril 90:60
Quack KC, Vassiliadou N, Pudney J, Anderson DJ, Hill JA (2001) Leukocyte activation in the decidua of chromosomally normal and abnormal fetuses from women with recurrent abortion. Hum Reprod 16:949–955
Quenby S, Bates M, Doig T, Brewster J, Lewis-Jones DI, Johnson PM, Vince G (1999) Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Hum Reprod 14:2386–2391
Rode L, Langhoff-Roos J, Andersson C, Dinesen J, Hammerum MS, Mohapeloa H, Tabor A (2009) Systematic review of progesterone for the prevention of preterm birth in singleton pregnancies. Acta Obstet Gynecol Scand 88:1180–1189
Rogenhofer N, Mittenzwei S, Thaler CJ, Diedrich K, Baumann K, Bohlmann MK (2011) Stellenwert der aktiven Immuntherapie bei Kinderwunschpatientinnen. Gyn Endokrinol 9:215–218
Royal College of Obstetricians and Gynaecologist – RCOG. Guideline No. 17. The investigation and treatment of couples with recurrent miscarriage. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_17.pdf. Zugegriffen am 06.07.2018
Sacks G (2015) Enough! Stop the arguments and get on with the science of natural killer cell testing. Hum Reprod 30:1526–1531
Salmassi A, Schmutzler AG, Schaefer S, Koch K, Hedderich J, Jonat W, Mettler L (2005) Is granulocyte colony-stimulating factor level predictive for human IVF outcome? Hum Reprod 20:2434–2440
Scarpellini F, Sbracia M (2009) Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod 24:2703–2708
Schindler AE (2005) Einsatz von Gestagenen in der Schwangerschaft – Therapeutische und präventive Anwendungsmöglichkeiten. Frauenarzt 46:586–589
Shakhar K, Rosenne E, Loewenthal R, Shakhar G, Carp H, Ben-Eliyahu S (2006) High NK cell activity in recurrent miscarriage: what are we really measuring? Hum Reprod 21:2421–2425
Steinvil A, Raz R, Berliner S, Steinberg DM, Zeltser D, Levran D, Shimron O, Sella T, Chodick G, Shalev V, Salomon O (2012) Association of common thrombophilias and antiphospholipid antibodies with success rate of in vitro fertilisation. Thromb Haemost 108:1192–1197
Strowitzki T, Germeyer A, Popovici R, von Wolff M (2006) The human endometrium as a fertility-determining factor. Hum Reprod Update 12:617–630
Sung N, Han AR, Park CW, Park DW, Park JC, Kim NY, Lim KS, Shin JE, Joo CW, Lee SE, Kim JW, Lee SK, Task Force IVIG (2017) Korean society for reproductive immunology. Intravenous immunoglobulin G in women with reproductive failure: The Korean society for reproductive immunology practice guidelines. Clin Exp Reprod Med 44:1–7
Tanaka T, Miyama M, Masuda M, Mizuno K, Sakamoto T, Umesaki N, Ogita S (2000) Production and physiological function of granulocyte colony-stimulating factor in non-pregnant human endometrial stromal cells. Gynecol Endocrinol 14:399–404
Toth B, Tempfer C, Bohlmann MK, Hancke K, Nawroth F, Schleußner E, Rogenhofer N, Rudnik-Schöneborn S, von Otte S, von Wolff M, Wischmann T, Würfel W, Zschocke J (2018) Diagnostik und Therapie beim wiederholten Spontanabort; AWMF-Leitlinie 015/050 (S2k). Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) (im Druck)
Wilczyński JR, Radwan P, Tchórzewski H, Banasik M (2012) Immunotherapy of patients with recurrent spontaneous miscarriage and idiopathic infertility: does the immunization-dependent Th2 cytokine overbalance really matter? Arch Immunol Ther Exp (Warsz) 60:151–160
Winger EE, Reed JL (2009) Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol 60:8–16
Winger EE, Reed JL, Ashoush S, Ahuja S, El-Toukhy T, Taranissi M (2009) Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol 61:113–120
Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M (2011a) Degree of TNF-α/IL-10 cytokine elevation correlates with IVF success rates in women undergoing treatment with Adalimumab (Humira) and IVIG. Am J Reprod Immunol 65:610–618
Winger EE, Reed JL, Ashoush S, El-Toukhy T, Ahuja S, Taranissi M (2011b) Birth defect rates in women using adalimumab (Humira) and intravenous immunoglobulin to treat immunologic-based infertility in IVF. Am J Reprod Immunol 66:237–241
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this entry
Cite this entry
Bohlmann, M.K. (2018). Immunologische Aspekte in der Reproduktionsmedizin. In: Diedrich, K., Ludwig, M., Griesinger, G. (eds) Reproduktionsmedizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55601-6_46-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-55601-6_46-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-55601-6
Online ISBN: 978-3-662-55601-6
eBook Packages: Springer Referenz Medizin